Share on StockTwits
 

Karyopharm Therapeutics (NASDAQ:KPTI) reached a new 52-week high during mid-day trading on Wednesday , AnalystRatingsNetwork.com reports. The company traded as high as $35.99 and last traded at $35.60, with a volume of 63,724 shares. The stock had previously closed at $34.76.

A number of research firms have recently commented on KPTI. Analysts at JMP Securities initiated coverage on shares of Karyopharm Therapeutics in a research note on Monday, December 2nd. They set an “outperform” rating and a $25.00 price target on the stock. Separately, analysts at Leerink Swann initiated coverage on shares of Karyopharm Therapeutics in a research note on Monday, December 2nd. They set an “outperform” rating on the stock. Finally, analysts at Bank of America initiated coverage on shares of Karyopharm Therapeutics in a research note on Monday, December 2nd. They set a “buy” rating and a $24.00 price target on the stock.

The stock has a 50-day moving average of $27.77 and a 200-day moving average of $22.7. The company’s market cap is $1.060 billion.

Karyopharm Therapeutics Inc is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.